News Conference News EuroPCR 2024 POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival Yael L. Maxwell May 22, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024
News Conference News EuroPCR 2024 NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD Michael O'Riordan May 14, 2024
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News EuroPCR 2022 CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial Yael L. Maxwell May 24, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Conference News EuroPCR 2019 Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis L.A. McKeown June 07, 2019
News Conference News EuroPCR 2018 ‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day Michael O'Riordan May 24, 2018